시장보고서
상품코드
1966123

상처 괴사조직제거 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Wound Debridement Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 142 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

상처 괴사조직제거 시장 규모는 2025년 52억 1,000만 달러에서 2034년에는 89억 5,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 6.2%로 성장할 전망입니다.

당뇨병성 족부궤양, 욕창, 정맥성 하지궤양과 같은 만성 상처의 유병률 증가로 인해 세계 상처 드레싱 시장은 꾸준히 성장하고 있습니다. 당뇨병, 비만, 고령화 인구의 증가로 인해 첨단 상처 치료 솔루션에 대한 수요가 크게 증가하고 있습니다. 병원과 외래진료센터에서는 치유 촉진과 감염 위험 감소를 위해 효소, 자가 용해, 기계적, 외과적 데브리드만 제품의 채택이 확대되고 있습니다. 생체활성 드레싱과 최소침습 기술의 기술 발전은 시장 확대를 더욱 촉진하고 있습니다.

주요 성장 요인으로는 만성질환 부담 증가, 상처 관리 프로토콜에 대한 인식 개선, 신흥시장에서의 의료 인프라 확충 등을 꼽을 수 있습니다. 외래 및 재택 의료 환경으로의 전환도 사용하기 쉽고 비용 효율적인 데브리드만 제품에 대한 수요를 증가시키고 있습니다. 선진국의 유리한 리베이트 정책과 첨단 생물학적 제제 및 하이드로겔 기반 제제의 지속적인 연구개발이 제조사 간 기술 혁신과 경쟁적 차별화를 뒷받침하고 있습니다.

의료시스템이 빠른 치료와 입원기간 단축을 우선시하는 가운데, 앞으로의 전망은 여전히 유망합니다. 디지털 상처 평가 도구와 원격의료 모니터링의 통합은 치료 결과를 향상시킬 수 있습니다. 특정 상처 유형에 특화된 항균 및 효소 솔루션의 채택 확대는 제품 포트폴리오를 더욱 확대할 것입니다. 그러나 저소득 지역의 가격 압박과 접근성 제한이 문제가 될 수 있기 때문에 제조업체는 저렴하면서도 효과적인 솔루션에 초점을 맞춰야 합니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 상처 괴사조직제거 시장 : 제품별

제5장 세계의 상처 괴사조직제거 시장 : 방법별

제6장 세계의 상처 괴사조직제거 시장 : 상처 유형별

제7장 세계의 상처 괴사조직제거 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

KSM 26.03.24

The Wound Debridement Market size is expected to reach USD 8.95 Billion in 2034 from USD 5.21 Billion (2025) growing at a CAGR of 6.2% during 2026-2034.

The global wound debridement market has experienced steady growth due to the increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Rising cases of diabetes, obesity, and aging populations have significantly contributed to demand for advanced wound care solutions. Hospitals and outpatient care centers increasingly adopt enzymatic, autolytic, mechanical, and surgical debridement products to accelerate healing and reduce infection risks. Technological advancements in bioactive dressings and minimally invasive techniques have further strengthened market expansion.

Key growth drivers include the rising burden of chronic diseases, greater awareness of wound management protocols, and expanding healthcare infrastructure in emerging markets. The shift toward outpatient and home healthcare settings has also increased demand for easy-to-use and cost-effective debridement products. Favorable reimbursement policies in developed countries and ongoing R&D in advanced biologics and hydrogel-based formulations are supporting innovation and competitive differentiation among manufacturers.

Future prospects remain promising as healthcare systems prioritize faster healing and reduced hospitalization time. Integration of digital wound assessment tools and telehealth monitoring may enhance treatment outcomes. Growing adoption of antimicrobial and enzymatic solutions tailored for specific wound types will further expand the product portfolio. However, pricing pressures and limited access in low-income regions may pose challenges, requiring manufacturers to focus on affordable yet effective solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Gels
  • Ointments & Creams
  • Surgical Devices
  • Ultrasound Devices
  • Mechanical Debridement Pads
  • Other Wound Debridement Products

By Method

  • Surgical Method
  • Enzymatic Method
  • Mechanical Method
  • Autolytic Method
  • Other

By Wound Type

  • Chronic Ulcers
  • Surgical & Traumatic Wounds
  • Burns

COMPANIES PROFILED

  • Acelity LP Inc, Smith Nephew, B Braun Melsungen AG, Coloplast AS, ConvaTec Group, Paul Hartmann, Mlnlycke Health Care, Lohmann Rauscher, Medline Industries, Integra Lifesciences

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL WOUND DEBRIDEMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Gels Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ointments & Creams Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Surgical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Ultrasound Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Mechanical Debridement Pads Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Other Wound Debridement Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL WOUND DEBRIDEMENT MARKET: BY METHOD 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Method
  • 5.2. Surgical Method Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Enzymatic Method Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Mechanical Method Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Autolytic Method Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL WOUND DEBRIDEMENT MARKET: BY WOUND TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Wound Type
  • 6.2. Chronic Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Surgical & Traumatic Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Burns Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL WOUND DEBRIDEMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Method
    • 7.2.3 By Wound Type
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Method
    • 7.3.3 By Wound Type
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Method
    • 7.4.3 By Wound Type
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Method
    • 7.5.3 By Wound Type
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Method
    • 7.6.3 By Wound Type
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL WOUND DEBRIDEMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Acelity L.P. Inc
    • 9.2.2 Smith & Nephew
    • 9.2.3 B. Braun Melsungen AG
    • 9.2.4 Coloplast A/S
    • 9.2.5 ConvaTec Group
    • 9.2.6 Paul Hartmann
    • 9.2.7 MA¶Lnlycke Health Care
    • 9.2.8 Lohmann & Rauscher
    • 9.2.9 Medline Industries
    • 9.2.10 Integra Lifesciences
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제